Cancer Immunology, Immunotherapy

Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma

Elizabeth M. E. Verdegaal, Conny Hoogstraten, Maro H. Sandel, Peter J. K. Kuppen, Antoinette A. T. P. Brink, Frans H. J. Claas, Michael C. B. Gorsira, J. Frans Graadt van Roggen, Susanne Osanto

Ii-Key/HER-2/neu(776-90) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors

Nectaria N. Sotiriadou, Nikoletta L. Kallinteris, Angelos D. Gritzapis, Ioannis F. Voutsas, Michael Papamichail, Eric von Hofe, Robert E. Humphreys, Theodoros Pavlis, Sonia A. Perez, Constantin N. Baxevanis

Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells

Azizul Haque, Arabinda Das, Laela M. Hajiaghamohseni, Austin Younger, Naren L. Banik, Swapan K. Ray

Bee venom secretory phospholipase A2 and phosphatidylinositol-homologues cooperatively disrupt membrane integrity, abrogate signal transduction and inhibit proliferation of renal cancer cells

Thomas Putz, Reinhold Ramoner, Hubert Gander, Andrea Rahm, Georg Bartsch, Katussevani Bernardo, Steven Ramsay, Martin Thurnher

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

François Ghiringhelli, Cedric Menard, Pierre Emmanuel Puig, Sylvain Ladoire, Stephan Roux, François Martin, Eric Solary, Axel Le Cesne, Laurence Zitvogel, Bruno Chauffert

Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy

Brandon Stott, Mladen Korbelik

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

Jon Amund Kyte, Gunnar Kvalheim, Kari Lislerud, Per thor Straten, Svein Dueland, Steinar Aamdal, Gustav Gaudernack

Tumor specific phage particles promote tumor regression in a mouse melanoma model

Fredrik Eriksson, W. David Culp, Robert Massey, Lars Egevad, Donita Garland, Mats A. A. Persson, Pavel Pisa

Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles

Takafumi Minami, Satoko Matsueda, Hiroko Takedatsu, Masahiro Tanaka, Masanori Noguchi, Hirotsugu Uemura, Kyogo Itoh, Mamoru Harada

Phase II study of interleukin-2 and 13-cis-retinoic acid as maintenance therapy in metastatic colorectal cancer

Francesco Recchia, Gaetano Saggio, Alisia Cesta, Giampiero Candeloro, Anna Di Blasio, Giovanna Amiconi, Marco Lombardo, Antonio Nuzzo, Angelo Lalli, Edoardo Alesse, Stefano Necozione, Silvio Rea

HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination

Teresa Cabrera, Ester Lara, José M. Romero, Isabel Maleno, Luis M. Real, Francisco Ruiz-Cabello, Pedro Valero, Francisco M. Camacho, Federico Garrido

HLA-A0201 positive pancreatic cell lines: new findings and discrepancies

Kuichun Zhu, Gregory Lizee, Pedro Cano, Marcelo Fernando-Vina, Baoan Ji, James L. Abbruzzese, Patrick Hwu, Laszlo Radvanyi, David Z. Chang

Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund–Wistar rats

Julie E. Heinrich, Morris Pollard, William A. Wolter, Zhong Liang, Hui Song, Elliot D. Rosen, Mark A. Suckow

Costimulation tunes tumor-specific activation of redirected T cells in adoptive immunotherapy

Andreas Hombach, Hinrich Abken

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

Christian Blank, Andreas Mackensen

Acknowledgement